- Telehealth Visits
- Insurance plan information
Vikaas S. Sohal, MD, PhD
Psychiatry- Telehealth Visits
- Insurance plan information
Psychiatry Mission Bay
Vikaas S. Sohal, MD, PhD
PsychiatryPsychiatry Mission Bay
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Vikaas S. Sohal is a psychiatrist who provides after-hours care for patients needing medication management for a variety of psychiatric conditions. He also supervises medical residents in a clinic for patients with early psychosis.
Sohal directs a neuroscience laboratory that investigates the brain circuits involved in psychiatric disorders.
After earning a bachelor's degree in applied mathematics at Harvard University, Sohal earned a master's degree in mathematics at the University of Cambridge in England. He earned his medical and doctoral degrees at Stanford University, where he also completed a residency in adult psychiatry.
Education & training
Board certification
- Psychiatry, American Board of Psychiatry and Neurology
Internship
- Psychiatry, Stanford University Medical Center-GME
Degree
- MD, Stanford University
My expertise
Specialties
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.